Search hospitals > California > Fremont
Center For Dermatology Cosmetic and Laser Surgery
Claim this profileFremont, California 94538
Conducts research for Atopic Dermatitis
Conducts research for Dermatitis
Conducts research for Eczema
Conducts research for Psoriasis
Conducts research for Medical Device Dermatitis
16 reported clinical trials
1 medical researcher
Summary
Center For Dermatology Cosmetic and Laser Surgery is a medical facility located in Fremont, California. This center is recognized for care of Atopic Dermatitis, Dermatitis, Eczema, Psoriasis, Medical Device Dermatitis and other specialties. Center For Dermatology Cosmetic and Laser Surgery is involved with conducting 16 clinical trials across 20 conditions. There are 1 research doctors associated with this hospital, such as Sunil Dhawan.Top PIs
Clinical Trials running at Center For Dermatology Cosmetic and Laser Surgery
Atopic Dermatitis
Eczema
Dermatitis
Amlitelimab
for Eczema
This is a multinational, multicenter, randomized, double-blind, placebo-controlled, parallel, Phase 3 study for treatment of participants aged 12 years and older diagnosed with moderate-to-severe atopic dermatitis (AD). The main objective of this study is to evaluate if those participants who received amlitelimab dose 1 in the parent studies (EFC17559 \[COAST-1\], EFC17560 \[COAST 2\], EFC17561 \[SHORE\]) and were responders can maintain their response either remaining at dose 1 or switching to dose 2 of amlitelimab compared to treatment withdrawal. Study details include: The study duration will be up to 68 weeks including a 52-week randomized double-blind period, and a 16-week safety follow-up for participants not entering the LTS17367 (RIVER-AD). The study duration will be up to 52 weeks for participants entering the LTS17367 \[RIVER-AD\] study at the Week 52 visit of EFC17600 (ESTUARY). The total treatment duration will be up to 52 weeks. The total number of visits will be up to 15 visits (or 14 visits for those entering LTS17367 \[RIVER-AD\] study).
Recruiting1 award Phase 33 criteria
Amlitelimab
for Atopic Dermatitis (COAST 1)
This trial tests an injectable treatment called amlitelimab for people aged 12 and older with moderate to severe eczema that doesn't respond well to creams or ointments. The treatment aims to reduce skin inflammation and itching by blocking specific proteins in the immune system. The study will evaluate how effective and safe amlitelimab is.
Recruiting1 award Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Center For Dermatology Cosmetic and Laser Surgery?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.